当前位置: X-MOL 学术Lancet Psychiatry › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Prevalence, correlates, tolerability-related outcomes, and efficacy-related outcomes of antipsychotic polypharmacy: a systematic review and meta-analysis
The Lancet Psychiatry ( IF 30.8 ) Pub Date : 2024-11-12 , DOI: 10.1016/s2215-0366(24)00314-6
Mikkel Højlund MD PhD, Ole Köhler-Forsberg MD DMSc, Anton T Gregersen BSc, Christopher Rohde MD PhD, Angelina I Mellentin PhD, Simon J Anhøj MD PhD, Adam F Kemp MD, Nina B Fuglsang MD, Anne Christine Wiuff MD, Louise Nissen MD PhD, Marc A Sørensen BSc, Nanna M Madsen BSc, Christina B Wagner MD PhD, Armaghan Agharazi BSc, Cecilie Søndergaard BSc, Marie Sandmark MD, Jana Reinhart MD, Prof Christoph U Correll MD

Antipsychotic polypharmacy remains a clinical reality, despite an increased risk of adverse events and little evidence of additional efficacy compared with antipsychotic monotherapy. In this systematic review and meta-analysis, we aimed to provide a comprehensive assessment of antipsychotic polypharmacy prevalence, trends, and correlates across mental disorders.

中文翻译:


抗精神病药物多药治疗的患病率、相关性、耐受性相关结局和疗效相关结局:系统评价和荟萃分析



尽管与抗精神病药单药治疗相比,不良事件的风险增加且几乎没有证据表明有额外的疗效,但抗精神病药多药治疗仍然是一种临床现实。在本系统评价和荟萃分析中,我们旨在提供对抗精神病药物多药治疗患病率、趋势和精神障碍相关性的全面评估。
更新日期:2024-11-12
down
wechat
bug